- Germany speeds up access to advanced therapies
- China’s draft patent linkage system
- Australia reclassified active medical device for therapy
- NICE encourages patients to have bigger input in choice of care
The population, intervention, comparator, and outcomes (PICO) element of the upcoming EU Joint Clini...
Read moreAUTHORS: Ella Odams, Richard Sloggett, Graham Foxon OBJECTIVES To evaluate if ChatGPT is a rel...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch